John B. Lynch, MD, MPH
Associate Professor
Department of Medicine, Division of Allergy & Infectious Diseases
Medical Director, HMC Infection Prevention & Control
Medical Director, HMC Employee Health
Medical Director, HMC Antimicrobial Stewardship Program
Sites of Practice: 
Harborview Medical Center
Related Links: 
UW Department of Global Health
Harborview Infectious Disease Clinic

Faculty Information

Biography

Dr. Lynch's focus is on the prevention of healthcare associated infections (HAI), rational use of antimicrobials, and employee health at Harborview Medical Center. In addition, he is an atttending physician in HMC Infectious Diseases Clinic where he sees patients with a broad spectrum of infectious diseases.

Current and recent research projects are focused on the epidemiology of HAI, appropriate infectious disease diagnosis, testing and treatment pathways, risk factors for Clostridium difficile infection, the use of antimicrobials, healthcare worker influenza vaccination, and preventable injury of healthcare workers.

Education & Training: 
MD
University of Washington
Seattle, WA
2001
MPH, Epidemiology/Global Health
University of Washington
Seattle, WA
2011
Fellow in Infectious Diseases
University of Washington
Seattle, WA
2005-2009
Post-doctoral Fellow, Overbaugh Lab
Fred Hutchinson Cancer Research Center
Seattle, WA
2006-2009
Honors: 
Alpha Omega Alpha Medical Honor Society
Morton N. Swartz Humanism in Medicine Award, Massachusetts General Hospital
Harborview Medical Center CARES Award, Infection Control Program
Contact
Email: 
jblynch@uw.edu
Phone: 
(206) 799-7859
Mailing Address: 

Harborview Medical Center
325 9th Ave
Box 359778
Seattle, WA 98104

Research & Clinical Interests
Research Interests: 
  • infection control
  • employee health
  • pandemic preparedness
  • antimicrobial resistance
  • employee health
Clinical Interests: 
  • infection control
  • employee health
  • pandemic preparedness
  • antimicrobial resistance
  • employee health
Publications
PubMed: 
PubMed Bibliography
Publications: 

Lynch JB. Multidrug-resistant Tuberculosis. Med Clin North Am. 2013 Jul; 97(4):553-79,ix-x.
• PubMed Abstract

Evans HL, McNamara E, Lynch JB, Chan JD, Dellit TH. Infection control for critically ill trauma patients: a systematic approach to prevention, detection and provider feedback. Crit Care Nurs Q. 2012 Jul-Sep; 35(3):241-6.
• PubMed Abstract

Chan JD, Dellit TH, Choudhuri JA,McNamara E, Melius EJ, Evans HL, Cuschieri J, Arbabi S, Lynch, JB. Active surveillance cultures of methicillin-resistant Staphylococcus aureus as a tool to predict methicillin-resistant S. aureus ventilator-associated pneumonia. Crit Care Med. 2012; 40(5):1437-42.
• PubMed Abstract

Clemens EC, Chan JC, Lynch JB, Dellit TH. Relationships between vancomycin minimum inhibitory concentration, dosing strategies, and outcomes in methicillin-resistant Staphylococcus aureus bacteremia. Diagn Microbiol and Infect Dis. 2011; 71(4):408-14.
• PubMed Abstract 

Choudhuri J, Pergamit R, Chan J, Schreuder AB, McNamara E, Lynch JB, Dellit TH. An electronic catheter-associated urinary tract infection surveillance tool. Infect Control Hosp Epidemiol. 2011; 32(8):757-62.
• PubMed Abstract

Lynch JB, Blish CA, John-Stewart G, Richardson B, Overbaugh J. The breadth and potency of passively acquired human immunodeficiency virus type 1-specific neutralizing antibodies does not correlate with risk of infant infection. J Virol. 2011; 85(11):5252-61.
• PubMed Abstract

Gulati RK, Choudhuri J, Fulton C, Chan JD, Evans HL, Lynch JB, Dellit TH. Outbreak of carbapenem-resistant Acinetobacter baumannii among non-burn patients in a burn intensive care unit. J Hosp Infect. 2010; 76(4):357-8.
• PubMed Abstract